Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
published in: Pharmacogenomics and Personalized Medicine
date of publication: 2017-08-23
main subject: bilirubin metabolic disorder, atazanavir
Cites articles 4
Date
Title
Article - wd:Q40052062